ERBB2 and breast cancer: TNBC, the most aggressive type of BC with a high proliferative and metastatic phenotype, is characterized by the absence of expression of the estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER-2) [1, 3].